Related Experiment Videos
Albendazole as a future antigiardial agent
J A Reynoldson1, R C Thompson, R J Horton
1School of Veterinary Studies, Murdoch University, Murdoch, Western Australia 6150, Australia.
Parasitology Today (Personal Ed.)
|December 1, 1992
Summary
Albendazole is a broad-spectrum benzimidazole anthelmintic effective against giardiasis. This article reviews its role in combating this parasitic infection.
Area of Science:
- Pharmacology
- Infectious Diseases
- Parasitology
Background:
- Benzimidazole carbamate anthelmintics represent a significant advancement in treating parasitic infections.
- Albendazole is a newer agent within this class, noted for its extensive activity spectrum.
- Giardiasis remains a prevalent parasitic disease requiring effective therapeutic options.
Purpose of the Study:
- To discuss the therapeutic role of Albendazole.
- To highlight its efficacy in managing giardiasis.
- To provide an overview of Albendazole's application in parasitic disease control.
Main Methods:
- Review of existing literature on Albendazole.
- Analysis of clinical data regarding Albendazole's use in giardiasis.
- Discussion of pharmacological properties and spectrum of activity.
Main Results:
- Albendazole demonstrates a broad spectrum of activity among benzimidazoles.
- The drug is effective in the treatment of giardiasis.
- Its pharmacological profile supports its use in parasitic infections.
Conclusions:
- Albendazole is a valuable therapeutic agent for giardiasis.
- Its broad-spectrum activity makes it a key drug in the management of parasitic infections.
- Further research may explore its utility in other parasitic conditions.